Hexa Reports Market Research Reports and Insightful Company Profiles
DNA Testing Market Share, Size, Trends and Growth, By Product Analysis, Application and Segment Forecasts To 2022
Global DNA testing market is anticipated to reach USD 10.04 billion by 2022, according to a new study by Grand View Research Inc. Rise in developments in the field of genome sequencing and personalized DNA level diagnostic applications, a considerable growth in the number of patented research initiatives by the government and government funded projects are factors expected to drive demand during the forecast period.
Introduction of novel technologies for genome profiling are expected to boost progress of this industry over the forecast period. Furthermore, increasing incidences of chronic oncology and infectious diseases that depend on DNA prototyping for treatment and diagnosis using personalized medicine are anticipated to significantly raise demand for DNA diagnostics/testing based research thereby propelling industrial growth in the coming years. Increasing demand for prenatal testing and in-vitro fertilization that subsequently leads to rise in demand for DNA diagnostics/testing is also attributive towards expected progress in this market
Browse Detail Report With TOC @ http://www.hexareports.com/report/dna-testing-market/details Further key findings from the study suggest:
PCR based diagnosis accounted for the largest share of the market revenue in 2014 as a result of higher preference rate coupled with higher availability of products and reagent kits of this segment. Next generation sequencing application for DNA testing is estimated to witness significant progress with a double digit CAGR of over 16% amongst the other technology segments due to presence of significant
Hexa Reports Market Research Reports and Insightful Company Profiles advantages offered by this technique of DNA identification and testing. Infectious disease diagnostics accounted for the largest market share in 2014 due to higher incidence rate of various infectious disorders which subsequently raises the demand for in-vitro nucleic acid based diagnostic tests for diagnosis and monitoring of disease progression.
There are diverse applications of DNA testing market out of which oncology diagnostics and histopathology is estimated to register lucrative growth over the forecast period. Factors attributing for considerable growth potential in this segment include identification of cancer causing genes & associated research, and facilitation in mutation detection North America dominated the market in 2014, with revenue estimated at over USD 2,600 million.
Presence of sophisticated healthcare infrastructure, rising incidence of genetic abnormalities, favorable government initiatives with respect to genetic diagnosis and its application in in-vitro fertilization are major factors driving growth of this region.
Asia Pacific is anticipated to witness lucrative growth as a result of developments in health care infrastructure in this region coupled with presence of significant number of target population that is suffering with chronic as well as acute disorders. Government initiatives taken up herein are also attributive to influence sector growth to a great extent.
Key participants of DNA testing industry include Abbott Laboratories, Agilent Technologies Inc., Illumina Inc., Beckman Coulter Inc., Bio-Rad Laboratories, Thermo Fisher Scientific, Applied Biosystems Group, Cepheid Inc., Transgenomic Inc., Siemens Healthcare, Roche Diagnostics, Qiagen, Illumina, GE Healthcare, Alere Inc, Affymetrix Inc., Hologic, Dako, and 454 Life Sciences.
Request A Sample copy of This Report @ http://www.hexareports.com/sample/101135 Table of Contents
Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions 1.3. List of Data Sources
Chapter 2. Executive Summary
Chapter 3. DNA Diagnostics/Testing Industry Outlook 3.1. Market Segmentation 3.2. Market Size and Growth Prospects
Hexa Reports Market Research Reports and Insightful Company Profiles 3.2.1. Market Driver Analysis 3.2.2. Market Restraint Analysis 3.3. DNA Diagnostics/Testing Market Dynamics 3.4. Key Opportunities Prioritized Technology Based 3.5. Key Opportunities Prioritized Application Based 3.6. Technology Positioning, 2014 3.6.1. Accuracy /Dynamic range 3.6.2. Price / cost per sample 3.6.3. Availability 3.6.4. Complexity 3.6.5. Technological advancements 3.6.6. Applications 3.6.7. Time consumption 3.7. Competitive Landscape for Companies, 2014 (Subject to data availability) 3.8. Industry Analysis Porters 3.9. DNA Diagnostics/Testing Market PESTEL Analysis
Chapter 4. DNA Diagnostics/Testing Technology Outlook 4.1. PCR Based Diagnostics 4.1.1. Market Estimates and Forecasts, 2012 2022 (USD Million) 4.2. NGS DNA Diagnosis 4.2.1. Market Estimates and Forecasts, 2012 2022 (USD Million) 4.3. In-situ Hybridization Diagnostics 4.3.1. Market Estimates and Forecasts, 2012 2022 (USD Million) 4.4. Micro-arrays Based Diagnostics 4.4.1. Market Estimates and Forecasts, 2012 2022(USD Million)
Browse Full Report @ http://www.hexareports.com/report/dna-testing-market/details
Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.
Hexa Reports Market Research Reports and Insightful Company Profiles Contact Information: Ryan Shaw Felton Office Plaza, 6265 Highway 9, Felton, California, 95018, United States Phone Number 1-800-489-3075 Email Us: email@example.com Our Website: http://www.hexareports.com/ Visit Our Blogs: http://hexareports.blogspot.in